HighVista Strategies’s Pharvaris PHVS Stock Holding History

HighVista Strategies’s Portfolio PHVS Stock Details PHVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.55M	Buy	160,494 +62,628	+64%	+$1.89M	1.27%	22
2026 Q1	$2.76M	Sell	97,866 -64,504	-40%	-$1.72M	0.76%	45
2025 Q4	$4.51M	Buy	+162,370	New	+$3.91M	1.16%	27
2025 Q3	–	Sell	-23,739	Closed	-$418K	–	168
2025 Q2	$418K	Buy	23,739 +971	+4%	+$15.6K	0.15%	134
2025 Q1	$357K	Hold	22,768	–	–	0.14%	134
2024 Q4	$436K	Hold	22,768	–	–	0.16%	126
2024 Q3	$422K	Buy	22,768 +6,018	+36%	+$110K	0.15%	137
2024 Q2	$315K	Hold	16,750	–	–	0.12%	134
2024 Q1	$387K	Buy	+16,750	New	+$445K	0.14%	127

Other funds holding PHVS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EFM

EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

HighVista Strategies's PHVS Position: Q2 2026 in Review

HighVista Strategies increased its Pharvaris (PHVS) stake by 64% in Q2 2026, buying an estimated $1.89M and bringing the position to 160,494 shares worth $5.55M. The position accounts for 1.27% of the portfolio, ranked #22.

HighVista Strategies first reported a position in PHVS in Q1 2024 and has held it in 9 quarters since. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

HighVista Strategies held 160,494 shares of Pharvaris worth $5.55M as of Q2 2026.
HighVista Strategies bought 62,628 Pharvaris shares in Q2 2026, an estimated $1.89M.
Pharvaris made up 1.27% of HighVista Strategies's portfolio in Q2 2026, its #22 holding.
HighVista Strategies first reported a position in Pharvaris in Q1 2024 and has held it in 9 quarters since.
125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.